Clinical trial
A Matched, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination When Compared to Laboratory Standard Procedures
NCT02102087 is registered in ClinicalTrials.gov with Magnolia Medical Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Matched, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination When Compared to Laboratory Standard Procedures
- Lead sponsor
- Magnolia Medical Technologies, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- October 31, 2015
- Enrollment
- 971 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septicemia